You are viewing an expired study
This study is not currently recruiting Study Participants on If you would like to find active studies please search for clinical trials

Tucson, Arizona

  • Nonalcoholic Steatohepatitis (NASH)


The purpose of this study is to determine the safety, tolerability, and efficacy of NGM282 in patients with nonalcoholic steatohepatitis.


Inclusion Criteria: - Males or females, between 18 and 75 years of age, inclusive - Histologically confirmed NASH diagnosis Exclusion Criteria: - Clinically significant acute or chronic liver disease - Prior liver transplantation



Primary Contact:

Study Director
NGM Study Director
NGM Biopharmaceuticals, Inc

Backup Contact:


Location Contact:

Tucson, Arizona
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source:

Date Processed: March 26, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on The form below is not enabled.